Skip to Main Content
American Flag
LABOR DAY SALE

50% off your first year of any Quiver subscription

...

Use Promo Code:

LABOR26
American Flag

Charles River Laboratories International, Inc.

CRL Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Compensation
Government
Ownership
News

$CRL is featured in our Rob Bresnahan strategy.

All Strategies
Income
Balance Sheet
Cash Flow
Revenue Breakdown

Recent trades of CRL by members of U.S. Congress

Politician Type Traded
Ro Khanna House / D Purchase $1,001 - $15,000 May 15, 2026
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 30, 2026
Ro Khanna House / D Sale $1,001 - $15,000 Feb 05, 2026
Robert Bresnahan House / R Sale $1,001 - $15,000 May 15, 2025
Jefferson Shreve House / R Sale $15,001 - $50,000 May 12, 2025
Jefferson Shreve House / R Purchase $15,001 - $50,000 May 08, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 15, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Apr 09, 2025
Robert Bresnahan House / R Purchase $15,001 - $50,000 Apr 08, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 12, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Mar 06, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 25, 2025
Ro Khanna House / D Purchase $1,001 - $15,000 Feb 19, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jan 22, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Jan 17, 2025
Julie Johnson House / D Purchase $1,001 - $15,000 Jan 15, 2025
Ro Khanna House / D Sale $1,001 - $15,000 Nov 03, 2023
Ro Khanna House / D Purchase $1,001 - $15,000 Oct 02, 2023
Lois Frankel House / D Sale $1,001 - $15,000 Sep 08, 2023
Lois Frankel House / D Purchase $1,001 - $15,000 Apr 25, 2023
Zoe Lofgren House / D Sale $1,001 - $15,000 Aug 25, 2022
Ro Khanna House / D Purchase $1,001 - $15,000 May 05, 2022
Zoe Lofgren House / D Purchase $1,001 - $15,000 Sep 30, 2021
Ro Khanna House / D Sale $1,001 - $15,000 Apr 07, 2020
Susie Lee House / D Sale $1,001 - $15,000 Oct 08, 2019
Susie Lee House / D Sale $1,001 - $15,000 Oct 07, 2019
Susie Lee House / D Purchase $1,001 - $15,000 Aug 29, 2019
Donna E. Shalala House / D Sale $1,001 - $15,000 Jun 24, 2019
Lamar Smith House / R Sale $1,001 - $15,000 Sep 26, 2018
Thomas MacArthur House / R Purchase $1,001 - $15,000 Sep 19, 2018
Thomas MacArthur House / R Purchase $1,001 - $15,000 Sep 13, 2018
Thomas MacArthur House / R Purchase $1,001 - $15,000 Sep 12, 2018
Thomas MacArthur House / R Purchase $1,001 - $15,000 Sep 11, 2018
Lamar Smith House / R Sale $1,001 - $15,000 Jul 26, 2018
Lamar Smith House / R Purchase $1,001 - $15,000 Feb 13, 2018
CRL Stock Insider Trading Activity Follow @QuiverQuant for major insider updates

---

Closing Price
Purchase
Sale
Name
Type
Shares
Price
Shares Held
Date
Reported
CRL Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
CRL Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported

Recently reported changes in CRL holdings by institutional investors

Quarterly net insider trading by CRL's directors and management

* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.

About

Backtest Start Date
CAGR (Total)
Return (30d)
Return (1Y)
  • 1M
  • 3M
  • 6M
  • YTD
  • 1Y
  • 2Y
  • 5Y
  • MAX

About

Backtest Start Date

Key Metrics

Return (1d)

Return (30d)

Return (1Y)

CAGR (Total)

Max Drawdown

Beta

Alpha

Sharpe Ratio

Win Rate

Average Win

Average Loss

Annual Volatility

Annual Std Dev

Information Ratio

Treynor Ratio

Total Trades

Show More
Metrics Definitions

Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.

  • Alpha

    Measures a portfolio's risk-adjusted performance against that of its benchmark

    Learn More about Alpha
  • Annual Standard Deviation

    Measures how much the portfolio's total return varies from its mean or average.

    Learn More about Annual Standard Deviation
  • Annual Volatility

    A statistical measure of the dispersion of returns for the portfolio.

    Learn More about Annual Volatility
  • Average Win

    The average return (%) for trades that resulted in a positive return.

  • Average Loss

    The average return (%) for trades that resulted in a negative return.

  • Beta

    A measure of the volatility of the portfolio compared to the market as a whole.

    Learn More about Beta
  • CAGR

    CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.

    Learn More about CAGR
  • Information Ratio

    A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.

    Learn More about Information Ratio
  • Max Drawdown

    the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.

    Learn More about Max Drawdown
  • Sharpe Ratio

    The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.

    Learn More about Sharpe Ratio
  • Total Trades

    The total number of trades made by this strategy.

  • Treynor Ratio

    Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.

    Learn More about Treynor Ratio
  • Win Rate

    The percentage of total trades that resulted in a positive return.

Subscribe to Quiver Premium for insider trading alerts

Be the first to see our newest insights and key updates across all datasets.

schema-2

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

Former government officials who have lobbied for CRL

16 former government officials from 9 congressional offices at 5 lobbying firms have lobbied for CRL, most recently Jul 21, 2026.

  • Kimberlee Trzeciak Congress FDA. Dep. Commissioner; 8/23-1/25. Assoc. Commissioner Leg. Affairs; 2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor, 2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA Formerly Health Policy Advisor · CAPITOL HILL CONSULTING GROUP · Jul 21, 2026
  • Emily Wilkinson-Holland Congress Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19). Formerly Price · CAPITOL HILL CONSULTING GROUP · Jul 21, 2026
  • Rick Boucher
    Christopher Davis House Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011). Formerly with Rick Boucher · CAPITOL HILL CONSULTING GROUP · Jul 21, 2026
  • Brian Sutter House Staff Dir. W&M Health subcommittee, Chairman Dave Camp April'13-Dec'14. Professional Staff, W&M Health subcommittee, Chairman Dave Camp, Jan'11-April'13. Leg Dir. Rep Dave Camp, May'08-Jan'11. Leg Asst Rep Dave Camp, Feb'03-May'08. Staff Ast July'02 Formerly Dave Camp · CAPITOL HILL CONSULTING GROUP · Jul 21, 2026
  • Sam Gejdenson
    Maya Seiden House Intern, WH Counsels Office; Intern, Rep. Sam Gejdenson; Sp. Asst to Cab Sec., WH; Advisor to CoS, Energy Dept.; Sp Asst to Sec of Energy; Sen Advisor, Off of Dep. Sec of State; CoS Office of the Dep Sec of State for Management and Res. Formerly with Sam Gejdenson · BGR GOVERNMENT AFFAIRS · Jan 20, 2026
  • John Stone House Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, Health Subcommittee; Intern, House E&C Formerly Counsel, House E&C Cmte, Oversight Subcommittee; Senior Counsel, House E&C Cmte, · BGR GOVERNMENT AFFAIRS · Jan 20, 2026
  • Elizabeth Warren
    Remy Mason Senate Senior FDA Policy Advisor to Senate HELP Committee Ranking Member Patty Murray; Senior Health Policy Advisor Sen. Elizabeth Warren; Intern to Rep. Allyson Schwartz Formerly with Elizabeth Warren · BGR GOVERNMENT AFFAIRS · Jan 20, 2026
  • Walker Roberts House Dep. COS, House Intl. Rel. Comm., Sp. Asst. to Pres. Formerly Dep. COS, House Intl. Rel. Comm., Sp. Asst. to Pres. · BGR GOVERNMENT AFFAIRS · Jan 20, 2023
See all 16 on the Revolving Door dashboard

CRL Estimated quarterly lobbying spending

Quiver Logo

No Corporate Lobbying data for this ticker

Corporate Lobbying Dashboard

CRL Revenue by Segment or Geography

By Segment
By Geography
Quiver Logo

No Revenue by Segment data for this ticker

Revenue Breakdown Dashboard
Quiver Logo

No Revenue by Geography data for this ticker

Revenue Breakdown Dashboard
CRL Income Statement
CRL Balance Sheet
CRL Cash Flow
U.S. Patents

New CRL patent grants

  • Patent Title: Detection of infectious agents from environmental air dust Jun. 23, 2026
  • Patent Title: Detection of infectious agents from environmental air dust Mar. 03, 2026
  • Patent Title: Detection of infectious agents from environmental air dust Feb. 10, 2026
  • Patent Title: Laboratory instrument Jan. 20, 2026
  • Patent Title: Container Jan. 06, 2026
  • Patent Title: Cartridge Nov. 11, 2025
  • Patent Title: Cho host cell protein assay Mar. 25, 2025
  • Patent Title: Detection of infectious agents from environmental air dust Mar. 04, 2025
  • Patent Title: Recombinant amebocyte lysate and uses thereof Dec. 03, 2024
  • Patent Title: Recombinantly-modified adeno-associated virus (raav) having improved packaging efficiency Dec. 03, 2024
  • Patent Title: Articles and methods involving detection of binding Nov. 05, 2024
  • Patent Title: Cho host cell protein assay Mar. 08, 2022
  • Patent Title: Heat-treated limulus amebocyte lysates Jan. 11, 2022
  • Patent Title: Method for mass humanization of non-human antibodies Sep. 21, 2021
  • Patent Title: Porous planar cell capture system and method of use Apr. 13, 2021
  • Patent Title: Detection of infectious agents from environmental air dust Mar. 23, 2021
  • Patent Title: Heat-treated Nov. 12, 2019
  • Patent Title: Heat-treated limulus amebocyte lysates Nov. 12, 2019
  • Patent Title: Ringed membrane Sep. 10, 2019
  • Patent Title: Filtration system Oct. 16, 2018
  • Patent Title: Depressor Sep. 25, 2018
  • Patent Title: Membrane holder Sep. 25, 2018
  • Patent Title: Scanning device adapter Jun. 26, 2018
  • Patent Title: Blister Jun. 26, 2018
  • Patent Title: Optical method for detecting viable microorganisms in a cell sample Jul. 18, 2017
  • Patent Title: Filtration system and use thereof Apr. 18, 2017
  • Patent Title: Filtration device Mar. 28, 2017
  • Patent Title: Adapter Jan. 10, 2017
  • Patent Title: Base Jan. 10, 2017
  • Patent Title: Cup Jun. 21, 2016
  • Patent Title: Cup Jun. 21, 2016
  • Patent Title: Cup May. 05, 2015
  • Patent Title: Cup assembly Apr. 14, 2015
  • Patent Title: Fluorescence-based viability staining method using a membrane permeable flourescent dye and membrane impermeable fluorescence quencher Mar. 31, 2015
  • Patent Title: Method of viability staining with membrane permeable fluorescent dye and membrane impermeable fluorescence quencher Mar. 31, 2015
  • Patent Title: Cup Mar. 17, 2015
  • Patent Title: Base assembly Nov. 11, 2014
  • Patent Title: Base Nov. 11, 2014
  • Patent Title: Cell capture system Nov. 11, 2014
  • Patent Title: Base with membrane and support May. 20, 2014
  • Patent Title: Base May. 20, 2014
  • Patent Title: Stage May. 13, 2014
  • Patent Title: Lid Feb. 04, 2014
  • Patent Title: Methods for the detection and/or quantification of gram positive bacterial contaminants May. 14, 2013
  • Patent Title: Computer display with a graphical user interface Sep. 18, 2012
  • Patent Title: Computer display with a graphical user interface Sep. 18, 2012
  • Patent Title: Computer display with a graphical user interface Sep. 11, 2012
  • Patent Title: Methods for the detection and/or quantification of gram positive bacterial contaminants Jun. 28, 2011
  • Patent Title: Methods for the detection of microbial contaminants May. 10, 2011
  • Patent Title: Method for classifying a microorganism in a biological sample Mar. 08, 2011
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded to CRL from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
CRL News

Recent insights relating to CRL

CNBC Recommendations

Recent picks made for CRL stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in CRL

CRL Analyst Ratings

CRL Stock Forecasts
...

  • ... Highest Price Target
  • ... Median Price Target
  • ... Lowest Price Target
CRL Analyst Forecasts
Analyst
Firm
Current
Previous
Date
Frequently Asked Questions
  • Is $CRL stock a Buy, Sell, or Hold?

  • What is the price target for $CRL stock?

* Analyst consensus is not financial advice. Please see our data disclaimers .

CRL Top Shareholders
Shareholder
Shares Held
CRL Options Owners
Shareholder
Security
Underlying Shares
Frequently Asked Questions
  • Who owns $CRL stock?

  • Who owns the most shares of $CRL stock?

  • What funds own $CRL stock?

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

CRL Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view CRL Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
About CRL

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provide in vitro (nonanimal) testing products, biologics testing services, and avian vaccine services.

  • Address Wilmington, MA
  • Market Cap 13.2 billion
  • Employees 19,700
  • Industrial Classification Services-Commercial Physical & Biological Research

Charles River Laboratories International, Inc. (CRL) Historical Stock Prices

Charles River Laboratories International, Inc. (CRL) closed at $277.33 on September 23, 2026. Over the past year its adjusted close ranged from $145.57 to $298.58. Daily prices go back to January 2, 2014, 3,200 trading days in all.

  • 1 month-7.12%
  • 3 months+37.22%
  • Year to date+39.03%
  • 1 year+84.58%
  • 3 years+38.93%
  • 5 years-39.49%
  • Max+424.45%
See every congressional and insider trade on the CRL price chart

Quiver Premium charts CRL's full daily history since 2014 with each congressional purchase and sale and every open-market insider purchase marked on the price line, with hover details for each trade.

Upgrade to Premium

Last 12 months, newest first

Access Raw Data Daily prices since 2014 for every ticker, through the Quiver API
DateOpenHighLowCloseAdj. CloseVolume
Sep 23, 2026 283.85 291.09 276.64 277.33 277.33 1,594,221
Sep 22, 2026 280.19 290.11 277.41 285.11 285.11 1,137,111
Sep 21, 2026 279.37 281.63 275.88 279.01 279.01 952,932
Sep 18, 2026 281.26 283.00 276.00 278.06 278.06 1,481,168
Sep 17, 2026 280.11 285.58 274.40 281.67 281.67 809,837
Sep 16, 2026 272.78 282.90 270.88 273.41 273.41 1,014,795
Sep 15, 2026 272.27 276.09 269.93 272.88 272.88 983,750
Sep 14, 2026 278.27 279.64 267.27 273.11 273.11 1,385,131
Sep 11, 2026 276.01 280.40 275.63 278.26 278.26 767,560
Sep 10, 2026 275.38 275.88 272.06 273.00 273.00 764,684
Sep 9, 2026 278.54 280.75 275.00 278.35 278.35 789,217
Sep 8, 2026 285.60 285.94 280.16 280.76 280.76 729,160
Sep 4, 2026 288.29 291.69 285.34 288.50 288.50 738,889
Sep 3, 2026 294.21 295.77 285.56 293.35 293.35 646,350
Sep 2, 2026 285.49 292.55 282.56 291.76 291.76 606,455
Sep 1, 2026 289.26 290.53 280.91 282.34 282.34 705,710
Aug 31, 2026 285.91 291.40 284.34 288.24 288.24 1,086,241
Aug 28, 2026 291.66 294.88 289.60 291.50 291.50 659,870
Aug 27, 2026 297.01 303.31 295.93 296.41 296.41 901,386
Aug 26, 2026 293.17 299.53 290.01 295.10 295.10 1,231,129
Aug 25, 2026 299.93 300.59 295.36 297.64 297.64 883,481
Aug 24, 2026 297.63 299.02 290.73 298.58 298.58 786,066
Aug 21, 2026 291.78 298.18 289.07 295.19 295.19 887,561
Aug 20, 2026 285.72 299.32 281.73 291.45 291.45 1,059,363
Aug 19, 2026 284.22 294.56 280.68 290.00 290.00 987,465
Aug 18, 2026 286.40 289.60 279.06 279.19 279.19 703,715
Aug 17, 2026 279.48 288.88 279.03 286.64 286.64 856,798
Aug 14, 2026 280.06 283.19 276.66 280.05 280.05 750,359
Aug 13, 2026 286.30 287.79 278.84 281.27 281.27 1,054,964
Aug 12, 2026 282.92 288.02 280.00 284.37 284.37 1,166,501
Aug 11, 2026 274.86 282.39 271.83 282.00 282.00 1,180,227
Aug 10, 2026 265.65 277.07 265.49 277.00 277.00 1,025,376
Aug 7, 2026 261.53 267.59 260.82 267.49 267.49 612,509
Aug 6, 2026 264.89 268.00 255.79 265.51 265.51 1,307,434
Aug 5, 2026 267.99 267.99 252.07 260.72 260.72 1,782,424
Aug 4, 2026 234.33 237.24 228.52 234.12 234.12 1,146,546
Aug 3, 2026 233.29 235.70 228.01 230.87 230.87 608,144
Jul 31, 2026 235.71 237.06 230.06 232.51 232.51 509,244
Jul 30, 2026 234.55 235.50 227.38 234.62 234.62 937,733
Jul 29, 2026 240.64 242.40 234.18 234.80 234.80 1,054,453
Jul 28, 2026 232.30 242.73 231.50 240.43 240.43 1,257,913
Jul 27, 2026 225.86 227.49 222.68 224.30 224.30 720,345
Jul 24, 2026 230.23 231.97 225.03 226.58 226.58 476,149
Jul 23, 2026 234.07 238.85 224.28 229.29 229.29 1,075,145
Jul 22, 2026 218.19 221.83 216.99 218.70 218.70 570,783
Jul 21, 2026 215.57 223.62 213.40 219.40 219.40 925,041
Jul 20, 2026 220.04 221.63 216.34 219.70 219.70 953,020
Jul 17, 2026 224.94 228.53 222.67 224.35 224.35 710,193
Jul 16, 2026 228.37 230.71 224.76 229.16 229.16 911,481
Jul 15, 2026 232.30 233.86 224.95 228.22 228.22 860,627
Jul 14, 2026 228.37 235.21 225.25 231.21 231.21 964,753
Jul 13, 2026 233.40 235.81 224.57 229.75 229.75 910,133
Jul 10, 2026 235.00 237.86 232.61 233.41 233.41 873,246
Jul 9, 2026 224.48 233.72 222.94 233.60 233.60 652,898
Jul 8, 2026 226.03 227.81 218.38 223.96 223.96 740,867
Jul 7, 2026 233.00 234.92 225.70 228.68 228.68 806,438
Jul 6, 2026 227.59 232.32 223.85 231.43 231.43 631,921
Jul 2, 2026 229.50 231.46 226.95 230.69 230.69 845,345
Jul 1, 2026 225.62 236.62 224.93 229.09 229.09 1,086,091
Jun 30, 2026 225.75 228.09 222.10 226.79 226.79 1,061,317
Jun 29, 2026 215.41 225.87 214.76 225.57 225.57 1,091,785
Jun 26, 2026 210.00 217.19 210.00 215.75 215.75 1,445,803
Jun 25, 2026 203.90 213.90 202.78 212.71 212.71 1,536,058
Jun 24, 2026 189.91 202.79 189.91 202.10 202.10 936,779
Jun 23, 2026 182.21 187.64 181.53 186.60 186.60 632,149
Jun 22, 2026 183.51 186.30 178.92 181.56 181.56 670,146
Jun 18, 2026 183.70 186.18 181.96 185.00 185.00 1,170,070
Jun 17, 2026 188.81 191.34 181.72 182.34 182.34 1,025,151
Jun 16, 2026 188.94 190.00 184.64 184.79 184.79 661,417
Jun 15, 2026 189.28 191.27 187.28 188.47 188.47 690,460
Jun 12, 2026 186.91 190.79 185.16 187.51 187.51 493,938
Jun 11, 2026 185.93 189.22 182.51 188.06 188.06 540,776
Jun 10, 2026 188.49 193.81 184.42 186.29 186.29 788,548
Jun 9, 2026 188.50 193.17 184.53 189.85 189.85 777,575
Jun 8, 2026 182.80 187.24 181.46 186.44 186.44 761,633
Jun 5, 2026 187.18 187.35 180.55 181.34 181.34 519,340
Jun 4, 2026 182.00 187.95 180.60 185.79 185.79 736,750
Jun 3, 2026 172.75 181.05 169.46 179.87 179.87 535,827
Jun 2, 2026 179.00 181.76 172.17 174.79 174.79 752,223
Jun 1, 2026 180.28 184.68 178.06 182.07 182.07 996,243
May 29, 2026 181.34 184.83 177.01 180.71 180.71 1,041,006
May 28, 2026 163.98 183.80 163.98 181.34 181.34 1,316,117
May 27, 2026 157.87 164.77 157.87 164.49 164.49 1,165,878
May 26, 2026 160.54 160.54 155.50 156.73 156.73 1,120,403
May 22, 2026 159.83 163.42 155.56 160.30 160.30 588,606
May 21, 2026 155.06 160.66 153.11 158.86 158.86 867,782
May 20, 2026 152.81 157.04 147.51 156.03 156.03 880,564
May 19, 2026 150.59 154.40 146.19 152.43 152.43 1,086,544
May 18, 2026 152.20 157.54 149.42 149.93 149.93 1,628,569
May 15, 2026 157.54 160.26 149.98 150.85 150.85 1,397,566
May 14, 2026 163.91 164.37 158.89 159.12 159.12 829,204
May 13, 2026 167.04 167.04 160.08 162.85 162.85 734,993
May 12, 2026 169.23 171.02 163.45 168.69 168.69 724,908
May 11, 2026 176.97 178.41 168.44 168.46 168.46 762,281
May 8, 2026 182.56 183.65 174.07 177.62 177.62 978,199
May 7, 2026 189.30 194.57 181.67 181.68 181.68 1,335,642
May 6, 2026 187.23 189.34 180.69 181.73 181.73 1,091,218
May 5, 2026 174.68 185.57 172.42 185.39 185.39 1,171,581
May 4, 2026 164.77 172.66 164.77 172.32 172.32 744,244
May 1, 2026 167.66 167.66 163.09 165.78 165.78 668,803
Apr 30, 2026 163.15 167.36 161.95 166.97 166.97 702,855
Apr 29, 2026 167.06 168.97 162.37 163.84 163.84 532,355
Apr 28, 2026 170.42 170.95 165.07 166.79 166.79 633,271
Apr 27, 2026 170.06 174.46 169.78 171.23 171.23 750,620
Apr 24, 2026 169.10 171.72 167.20 169.80 169.80 716,339
Apr 23, 2026 178.65 180.85 165.55 167.74 167.74 1,237,876
Apr 22, 2026 185.51 185.84 181.72 184.80 184.80 865,936
Apr 21, 2026 186.18 190.14 182.07 183.10 183.10 445,009
Apr 20, 2026 181.12 186.83 181.12 185.54 185.54 576,718
Apr 17, 2026 180.31 185.61 179.06 183.88 183.88 745,280
Apr 16, 2026 178.94 185.00 175.79 176.94 176.94 915,066
Apr 15, 2026 180.80 184.61 177.38 180.56 180.56 976,334
Apr 14, 2026 181.90 183.80 179.24 179.31 179.31 875,439
Apr 13, 2026 177.47 179.75 173.23 178.34 178.34 636,235
Apr 10, 2026 176.10 176.27 172.59 175.65 175.65 487,926
Apr 9, 2026 175.00 176.17 170.20 175.55 175.55 839,192
Apr 8, 2026 178.14 180.79 173.94 175.07 175.07 978,958
Apr 7, 2026 167.06 170.97 166.06 169.54 169.54 686,859
Apr 6, 2026 170.56 173.86 161.53 168.22 168.22 1,344,540
Apr 2, 2026 170.53 179.83 170.52 173.89 173.89 839,210
Apr 1, 2026 173.77 176.20 171.66 174.90 174.90 915,715
Mar 31, 2026 162.55 172.57 162.03 172.50 172.50 1,180,103
Mar 30, 2026 161.55 163.30 158.24 159.72 159.72 872,985
Mar 27, 2026 163.60 163.60 153.25 159.16 159.16 814,281
Mar 26, 2026 164.33 168.24 164.33 165.13 165.13 909,097
Mar 25, 2026 163.82 166.01 159.17 165.89 165.89 1,033,641
Mar 24, 2026 155.06 161.16 153.63 159.19 159.19 598,229
Mar 23, 2026 156.65 159.35 153.99 158.00 158.00 984,242
Mar 20, 2026 152.86 155.88 150.82 153.60 153.60 808,601
Mar 19, 2026 156.04 158.84 152.89 153.05 153.05 790,934
Mar 18, 2026 151.62 158.16 149.63 157.11 157.11 804,889
Mar 17, 2026 155.50 158.77 153.08 153.71 153.71 755,080
Mar 16, 2026 157.67 158.51 151.68 151.97 151.97 791,033
Mar 13, 2026 155.62 158.76 153.04 155.46 155.46 987,639
Mar 12, 2026 166.07 166.46 151.89 152.66 152.66 1,414,786
Mar 11, 2026 166.73 170.16 166.47 168.91 168.91 604,899
Mar 10, 2026 173.95 175.28 166.82 167.37 167.37 793,576
Mar 9, 2026 172.73 178.05 168.21 176.99 176.99 1,029,086
Mar 6, 2026 178.89 179.86 172.92 174.46 174.46 1,078,851
Mar 5, 2026 177.68 182.65 177.68 181.32 181.32 1,145,086
Mar 4, 2026 176.06 181.01 175.50 179.58 179.58 742,853
Mar 3, 2026 173.92 178.42 172.05 175.69 175.69 790,343
Mar 2, 2026 175.29 179.20 173.22 178.61 178.61 835,459
Feb 27, 2026 172.08 179.82 170.00 178.49 178.49 1,198,281
Feb 26, 2026 168.08 175.48 166.59 175.46 175.46 1,632,502
Feb 25, 2026 169.91 171.05 166.60 167.56 167.56 982,200
Feb 24, 2026 162.35 168.98 161.43 166.06 166.06 768,781
Feb 23, 2026 168.01 170.17 159.54 163.52 163.52 1,499,318
Feb 20, 2026 162.54 171.93 161.46 168.92 168.92 1,599,564
Feb 19, 2026 154.09 165.12 151.31 164.24 164.24 2,055,876
Feb 18, 2026 146.82 158.45 146.33 158.00 158.00 2,541,298
Feb 17, 2026 160.74 164.36 157.82 158.53 158.53 1,936,969
Feb 13, 2026 160.44 163.32 156.58 161.35 161.35 1,102,265
Feb 12, 2026 157.49 162.62 148.34 158.74 158.74 2,827,050
Feb 11, 2026 183.06 183.11 162.95 165.98 165.98 1,979,681
Feb 10, 2026 182.00 184.45 178.27 181.24 181.24 1,055,375
Feb 9, 2026 187.34 188.70 183.94 185.70 185.70 853,350
Feb 6, 2026 184.89 191.50 182.47 189.21 189.21 987,656
Feb 5, 2026 200.64 201.72 181.77 183.70 183.70 1,241,363
Feb 4, 2026 202.68 203.74 198.21 201.62 201.62 847,523
Feb 3, 2026 214.30 218.69 200.17 201.41 201.41 963,819
Feb 2, 2026 208.86 213.66 206.85 213.22 213.22 402,997
Jan 30, 2026 210.37 212.59 208.11 210.48 210.48 384,520
Jan 29, 2026 216.45 217.73 210.14 211.68 211.68 554,484
Jan 28, 2026 218.45 219.37 214.48 216.88 216.88 444,601
Jan 27, 2026 220.53 224.78 219.46 219.53 219.53 401,234
Jan 26, 2026 219.13 222.67 218.03 222.35 222.35 505,926
Jan 23, 2026 223.10 223.19 217.57 219.61 219.61 576,850
Jan 22, 2026 228.39 228.39 222.30 224.03 224.03 521,256
Jan 21, 2026 219.52 226.93 219.52 226.77 226.77 521,014
Jan 20, 2026 217.46 223.62 216.03 218.19 218.19 718,726
Jan 16, 2026 223.43 227.50 218.90 219.70 219.70 866,972
Jan 15, 2026 216.48 224.43 214.11 223.47 223.47 779,526
Jan 14, 2026 219.15 221.52 215.23 216.39 216.39 936,397
Jan 13, 2026 221.66 228.88 215.00 218.99 218.99 1,054,449
Jan 12, 2026 221.22 222.28 213.46 218.82 218.82 743,956
Jan 9, 2026 217.82 222.37 216.88 220.91 220.91 1,133,489
Jan 8, 2026 213.90 216.97 208.67 215.51 215.51 995,069
Jan 7, 2026 216.41 217.89 215.02 216.77 216.77 732,176
Jan 6, 2026 208.35 216.76 208.35 216.11 216.11 752,620
Jan 5, 2026 197.00 208.69 194.93 208.32 208.32 710,810
Jan 2, 2026 200.13 203.00 198.56 202.42 202.42 483,450
Dec 31, 2025 202.53 202.53 199.45 199.48 199.48 312,022
Dec 30, 2025 202.77 203.63 200.90 201.98 201.98 300,861
Dec 29, 2025 203.17 205.00 202.52 203.16 203.16 471,472
Dec 26, 2025 203.42 204.19 202.32 203.66 203.66 293,262
Dec 24, 2025 202.69 204.01 201.04 203.16 203.16 241,982
Dec 23, 2025 202.20 204.07 201.56 202.87 202.87 462,230
Dec 22, 2025 196.99 204.47 196.99 203.02 203.02 631,702
Dec 19, 2025 193.46 198.34 191.89 197.06 197.06 1,174,534
Dec 18, 2025 197.32 199.93 193.63 193.85 193.85 670,804
Dec 17, 2025 194.56 198.95 194.56 195.98 195.98 586,926
Dec 16, 2025 197.31 198.32 194.50 195.22 195.22 722,519
Dec 15, 2025 197.08 200.58 195.10 198.15 198.15 843,224
Dec 12, 2025 194.37 195.51 192.09 193.03 193.03 515,160
Dec 11, 2025 194.93 196.38 192.38 194.43 194.43 639,012
Dec 10, 2025 187.59 195.06 186.10 194.85 194.85 1,107,338
Dec 9, 2025 186.80 191.34 185.93 185.99 185.99 1,070,104
Dec 8, 2025 184.39 189.15 183.43 187.12 187.12 810,819
Dec 5, 2025 185.01 185.90 182.71 184.31 184.31 705,080
Dec 4, 2025 186.61 186.72 176.37 184.04 184.04 992,766
Dec 3, 2025 180.91 185.93 180.00 184.67 184.67 770,517
Dec 2, 2025 173.99 177.01 172.95 174.76 174.76 636,420
Dec 1, 2025 177.32 180.95 175.71 176.09 176.09 896,786
Nov 28, 2025 178.00 178.55 176.93 178.14 178.14 225,766
Nov 26, 2025 179.00 179.19 176.66 178.94 178.94 351,032
Nov 25, 2025 170.51 178.55 170.51 178.05 178.05 789,481
Nov 24, 2025 167.56 171.72 167.45 170.44 170.44 1,747,360
Nov 21, 2025 163.59 172.39 157.49 167.64 167.64 1,342,710
Nov 20, 2025 162.87 165.48 160.71 162.08 162.08 579,385
Nov 19, 2025 161.83 162.65 156.72 161.64 161.64 751,570
Nov 18, 2025 162.75 164.36 160.49 162.53 162.53 1,289,452
Nov 17, 2025 167.69 170.54 162.72 162.74 162.74 714,199
Nov 14, 2025 167.08 169.00 165.05 167.81 167.81 1,894,496
Nov 13, 2025 169.34 175.12 168.28 169.21 169.21 1,144,288
Nov 12, 2025 173.03 174.45 171.06 171.50 171.50 1,056,862
Nov 11, 2025 169.70 175.55 167.60 173.50 173.50 929,261
Nov 10, 2025 167.14 172.83 166.96 168.97 168.97 1,163,791
Nov 7, 2025 168.91 171.50 165.74 168.05 168.05 900,950
Nov 6, 2025 167.72 175.00 165.70 170.88 170.88 1,906,791
Nov 5, 2025 163.29 170.14 160.01 167.70 167.70 2,827,079
Nov 4, 2025 176.04 180.19 175.83 177.85 177.85 1,172,772
Nov 3, 2025 178.46 178.94 173.89 178.86 178.86 670,728
Oct 31, 2025 178.39 181.56 178.17 180.07 180.07 950,252
Oct 30, 2025 177.12 182.06 177.12 179.11 179.11 784,702
Oct 29, 2025 186.71 191.41 175.58 180.15 180.15 1,590,873
Oct 28, 2025 193.45 193.47 187.03 187.93 187.93 1,102,993
Oct 27, 2025 197.24 198.00 193.41 195.28 195.28 937,136
Oct 24, 2025 194.11 199.66 191.48 197.04 197.04 1,741,746
Oct 23, 2025 191.00 195.25 188.97 190.97 190.97 1,075,623
Oct 22, 2025 190.69 190.69 184.88 187.00 187.00 1,376,859
Oct 21, 2025 185.00 190.41 184.99 188.26 188.26 1,049,335
Oct 20, 2025 179.35 184.23 178.52 184.14 184.14 815,788
Oct 17, 2025 173.16 178.77 172.72 178.52 178.52 1,027,431
Oct 16, 2025 172.95 177.75 172.00 174.95 174.95 1,304,190
Oct 15, 2025 170.22 173.02 168.71 170.72 170.72 531,291
Oct 14, 2025 168.43 172.41 166.86 170.13 170.13 580,708
Oct 13, 2025 170.07 172.21 167.69 170.64 170.64 698,240
Oct 10, 2025 172.47 174.37 166.93 167.03 167.03 725,392
Oct 9, 2025 173.40 174.73 171.30 172.14 172.14 883,651
Oct 8, 2025 170.00 174.34 168.99 173.47 173.47 917,775
Oct 7, 2025 175.23 176.15 168.32 170.10 170.10 900,397
Oct 6, 2025 178.15 179.64 174.76 174.95 174.95 856,757
Oct 3, 2025 176.00 181.45 175.97 177.33 177.33 1,112,649
Oct 2, 2025 173.25 178.19 173.15 175.36 175.36 1,714,736
Oct 1, 2025 156.06 170.66 156.06 170.48 170.48 1,292,164
Sep 30, 2025 147.54 156.79 146.90 156.46 156.46 1,049,297
Sep 29, 2025 148.92 148.92 145.47 146.99 146.99 752,833
Sep 26, 2025 146.00 149.17 145.32 148.56 148.56 762,931
Sep 25, 2025 148.39 148.39 144.26 145.57 145.57 884,217
Sep 24, 2025 150.13 150.87 147.46 149.45 149.45 1,276,195
Sep 23, 2025 154.22 154.94 149.91 150.25 150.25 786,840

Open, high, low and close are the prices as traded. Adjusted close accounts for splits and dividends, and is what the chart and returns use. Where a company changed its ticker, its history under the old symbol is included.

Need daily prices for every ticker, in code?

The Quiver API serves daily prices back to 2014 alongside congressional trades, insider trades, 13F holdings and lobbying, all under one key and inside Claude or ChatGPT through our MCP server.

Explore the Quiver API
Charles River Laboratories International, Inc. Executive Compensation

We estimate that -- received a compensation of -- in --, making them the highest paid executive at CRL, per a recent SEC DEF 14A filing. We estimate that the median employee at CHARLES RIVER LABORATORIES INTERNATIONAL, INC. is paid $55,870.



Name
Role
Salary
Bonus
Stock/Option Awards
Total Compensation